| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2013 | CN102908317A Macrolide antibiotics enteric-coated pellets and coating solution thereof |
| 02/06/2013 | CN102908316A Ivermectin water-soluble solid dispersion and preparation method thereof |
| 02/06/2013 | CN102908314A Silybin proliposomes preparation, and preparation method and application method thereof |
| 02/06/2013 | CN102908313A Veterinary albendazole suspension and preparation method thereof |
| 02/06/2013 | CN102908312A Liquid combination for resisting hepatitis B viruses |
| 02/06/2013 | CN102908311A Tolfenamic acid injection and preparation method and application thereof |
| 02/06/2013 | CN102908310A Meloxicam injection for treating chronic infectious arthritis of dogs and cats |
| 02/06/2013 | CN102908309A Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 02/06/2013 | CN102908307A Dronedarone hydrochloride pharmaceutical composition for injection and preparation method thereof |
| 02/06/2013 | CN102908306A Fibrauretine external preparation for beasts and birds and preparation method thereof |
| 02/06/2013 | CN102908305A Dronedarone hydrochloride-containing oral solid medicinal composition and preparation method thereof |
| 02/06/2013 | CN102907671A Preparation method and application of pectin enzymatic hydrolysis product having functions of dispelling effects of alcohol and resisting drunk |
| 02/06/2013 | CN102907606A Beta-glucan composition and application thereof |
| 02/06/2013 | CN102397264B Method for preparing sinomenine hydrochloride sustained-release tablet |
| 02/06/2013 | CN102389439B Application of Valvate Kiwifruit glycoside E and Valvate Kiwifruit glycoside F in preparation of medicaments for resisting myocardial ischemia |
| 02/06/2013 | CN102382126B Cefuroxime-L-arginine hydrate and application thereof |
| 02/06/2013 | CN102382111B Sulfo-tetrahydro-pyridino-dihydro-pyrimidone derivative, preparation method for same and application thereof |
| 02/06/2013 | CN102370646B Substance for protecting heart |
| 02/06/2013 | CN102366623B Preparation method of traditional Chinese medicine for treating qi deficiency-type bedsore |
| 02/06/2013 | CN102311475B New compound separated from Ganoderma lucidum, preparation method thereof and medicinal purpose thereof |
| 02/06/2013 | CN102274150B Gargle for relieving thirsty symptom and preparation method thereof |
| 02/06/2013 | CN102266313B Method for establishing zebra fish thrombosis model |
| 02/06/2013 | CN102247372B Methionine-containing medicinal composition and preparation method thereof |
| 02/06/2013 | CN102225105B Medicine for treating migraine |
| 02/06/2013 | CN102210717B Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
| 02/06/2013 | CN102190815B Chitosan derivative self-crosslinked antimicrobial hydrogel using oxidized konjak as crosslinking agent and preparation method thereof |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/06/2013 | CN102137659B Microparticles |
| 02/06/2013 | CN102133231B Product prepared by shark cartilage for supplementing calcium and promoting metabolism and development of cartilage and preparation method thereof |
| 02/06/2013 | CN102133179B Stable cetirizine oral solution |
| 02/06/2013 | CN102058520B Cream for promoting tissue regeneration and restraining sores and preparation method thereof |
| 02/06/2013 | CN102037989B Aqueous compositions for disinfection and/or sterilization |
| 02/06/2013 | CN102014925B Fulvestrant formulations |
| 02/06/2013 | CN102014904B Liquid formulation for deferiprone with palatable taste |
| 02/06/2013 | CN101926786B Sustained release preparation for cantharidin and cantharidin extract |
| 02/06/2013 | CN101925576B Kappa selective opioid receptor antagonist |
| 02/06/2013 | CN101897760B Detection method of Santanning syrup |
| 02/06/2013 | CN101879427B Doxorubicin hydrochloride-carrying natural polymer-poly(3-benzene acid acrylamide) composite nanospheres, manufacturing method and application thereof |
| 02/06/2013 | CN101874032B Novel naphthyridine derivative monohydrate and method for producing the same |
| 02/06/2013 | CN101861321B Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors |
| 02/06/2013 | CN101827856B 2 ' -fluoro-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 02/06/2013 | CN101809018B Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate and using method thereof |
| 02/06/2013 | CN101778628B Methods for treating anxiety |
| 02/06/2013 | CN101743001B Combination anticoagulant therapy with a compound that acts as a factor XA inhibitor |
| 02/06/2013 | CN101712672B Novel compound for treating diseases of cardiovascular and cerebrovascular systems, preparation method and application thereof |
| 02/06/2013 | CN101679272B Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands |
| 02/06/2013 | CN101675046B Therapeutic agents |
| 02/06/2013 | CN101665518B Phosphoryl carboxylic acid salinomycin ester derivative and preparing method thereof |
| 02/06/2013 | CN101657455B Compounds for the treatment of hepatitis C |
| 02/06/2013 | CN101583366B Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 02/06/2013 | CN101554382B New purpose of triterpene substance |
| 02/06/2013 | CN101528743B Fused heterocyclic derivatives and methods of use |
| 02/06/2013 | CN101490028B C-phenyl glycitol compound |
| 02/06/2013 | CN101478950B Aqueous suspensions of TMC278 |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/06/2013 | CN101362717B 4-(4-amidoanilino)-2-(methylcarbamoyl) pyridine, derivates thereof and preparation, application thereof |
| 02/06/2013 | CN101314775B RNA disturbance target point capable of being used for treating AIDS |
| 02/06/2013 | CN101272762B Sachet formulation for amine polymers |
| 02/06/2013 | CN101243096B 抗病毒化合物 Antiviral compounds |
| 02/06/2013 | CN101235071B Diene oleanolic acid pentacyclic triterpenes derivatives and use thereof |
| 02/06/2013 | CN101227896B Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/06/2013 | CN101203615B Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations |
| 02/06/2013 | CN101198334B Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders |
| 02/06/2013 | CN101166736B Polymorph form II of tanaproget |
| 02/06/2013 | CN101163480B Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 02/06/2013 | CN101142218B Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 02/05/2013 | US8367848 Process for the preparation of amorphous calcium salt of atorvastatin |
| 02/05/2013 | US8367843 Phenol derivative |
| 02/05/2013 | US8367838 Amines or amino alcohols as GLYT1 inhibitors |
| 02/05/2013 | US8367836 Pyridinone antagonists of alpha-4 integrins |
| 02/05/2013 | US8367835 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 02/05/2013 | US8367826 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/05/2013 | US8367825 Substituted pyrimidinyl oxime kinase inhibitors |
| 02/05/2013 | US8367738 Smooth muscle contraction inhibitors |
| 02/05/2013 | US8367737 Method of using biothionol and biothionol-like compounds as anti-angiogenic agents |
| 02/05/2013 | US8367736 Anticancer composition comprising obovatol or obovatal |
| 02/05/2013 | US8367735 Pharmaceutical compositions |
| 02/05/2013 | US8367734 Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| 02/05/2013 | US8367733 Composition for attenuation of pain or wound healing agents in dosage |
| 02/05/2013 | US8367732 Di-fluoro containing compounds as cysteine protease inhibitors |
| 02/05/2013 | US8367730 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration |
| 02/05/2013 | US8367729 Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders |
| 02/05/2013 | US8367727 Method of using abscisic acid to treat diseases and disorders |
| 02/05/2013 | US8367726 Acid salt of tolterodine having effective stability for transdermal drug delivery system |
| 02/05/2013 | US8367725 Composition and/or method for preventing onset and/or recurrence of cardiovascular events |
| 02/05/2013 | US8367723 Selenoquinone-derived active organometallic complexes, methods for synthesizing same, and uses thereof |
| 02/05/2013 | US8367722 Methods of using prodrugs of pregabalin |
| 02/05/2013 | US8367721 Methods of treating an overweight or obese subject |
| 02/05/2013 | US8367720 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/05/2013 | US8367719 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 02/05/2013 | US8367718 Epigallocatechin gallate trimer and α-glucosidase inhibitor containing epigallocatechin gallate polymer |
| 02/05/2013 | US8367717 High performance solution processable semiconductor based on dithieno [2,3-D:2′, 3′-D′]benzo[1,2-B:4,5-B′] dithiophene |
| 02/05/2013 | US8367716 Method for attentuating virulence of microbial pathogens and for inhibiting microbial biofilm formation |
| 02/05/2013 | US8367715 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 02/05/2013 | US8367714 Cannabinoid receptor targeted agent |
| 02/05/2013 | US8367713 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| 02/05/2013 | US8367712 Substituted amide beta secretase inhibitors |
| 02/05/2013 | US8367711 Angiotensin II receptor antagonists |
| 02/05/2013 | US8367710 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 02/05/2013 | US8367709 Dipeptide analogs as coagulation factor inhibitors |